The Risk of Endophthalmitis Following Intravitreal Triamcinolone Injection in the DRCRnet and SCORE Clinical Trials

Por Bhavsar, Abdhish R., Ip, Michael S., Glassman, Adam R.
Publicado em 2007

Evaluation of Results 1 Year Following Short-term Use of Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy

Por Bhavsar, Abdhish R., Torres, Karisse, Glassman, Adam R., Jampol, Lee M., Kinyoun, James L.
Publicado no JAMA Ophthalmol (2014)

Update on Risk of Endophthalmitis after Intravitreal Drug Injections and Potential Impact of Elimination of Topical Antibiotics

Por Bhavsar, Abdhish R., Stockdale, Cynthia R., Ferris, Frederick L., Brucker, Alexander J., Bressler, Neil M., Glassman, Adam R.
Publicado em 2012

The Risk of Endophthalmitis Following Intravitreal Injection in the DRCR.net Laser-Ranibizumab-Triamcinolone Clinical Trials

Por Bhavsar, Abdhish R., Googe, Joseph M., Stockdale, Cynthia R., Bressler, Neil M., Brucker, Alexander J., Elman, Michael J., Glassman, Adam R.
Publicado em 2009

Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial

Por Maturi, Raj K., Glassman, Adam R., Liu, Danni, Beck, Roy W., Bhavsar, Abdhish R., Bressler, Neil M., Jampol, Lee M., Melia, Michele, Punjabi, Omar S., Salehi-Had, Hani, Sun, Jennifer K.
Publicado no JAMA Ophthalmol (2017)

Randomized Clinical Trial Evaluating Intravitreal Ranibizumab or Saline for Vitreous Hemorrhage from Proliferative Diabetic Retinopathy

Por Bhavsar, Abdhish R., Torres, Karisse, Beck, Roy W., Bressler, Neil M., Ferris, Frederick L., Friedman, Scott M., Glassman, Adam R., Maturi, Raj K., Melia, Michele, Singer, Michael A., Stockdale, Cynthia R.
Publicado em 2013